ULBI on Nasdaq
Ultralife Corporation
American industrial electrical equipment manufacturer
Ultralife Corporation designs and manufactures batteries and communications systems worldwide. Ultralife serves government and defense, medical, safety and security, energy, robotics and other customers across the globe through the design and development of a range of products. Founded in 1991 when launched as an Initial Public Offering (IPO) evolving from Kodak’s Ultra Technologies battery division, and headquartered in Newark, New York, the Company’s business segments include battery and energy products and communications systems.3 It employed 573 people in 2019.1 Its revenue was $107 million in 2019.1 Its shares trade on Nasdaq under the symbol ULBI.1 Wikipedia text CC BY-SA 4.0
Price unavailable
Last updated Oct 21, 2026.
Overview
Compare with CBAK Energy Technology Inc., Energy Vault or Byrna Technologies Inc., or pick any stock.
- TickerULBI on Nasdaq1
- IndustryMiscellaneous Electrical Machinery, Equipment & Supplies1
- HeadquartersNewark1
- Websiteultralifecorporation.com
- Legal formpublic company1
- Incorporated inDE5
- Business address2000 Technology Parkway, Newark, Ny 145135
- Filer categoryAccelerated filer, Smaller reporting company5
- LEI529900NVAFLKA00F3U054
- StatusActive4
- LEI statusLapsed (not renewed)4
- Registered addressc/o THE CORPORATION TRUST COMPANY, CORPORATION TRUST CENTER 1209 ORANGE ST, 19801 Wilmington, United States4
- Registered withDivision of Corporations, Department of State, 22493794
See how the biggest companies compare on our leaderboards
Ultralife Corporation designs and manufactures batteries and communications systems worldwide. Ultralife serves government and defense, medical, safety and security, energy, robotics and other customers across the globe through the design and development of a range of products. Founded in 1991 when launched as an Initial Public Offering (IPO) evolving from Kodak’s Ultra Technologies battery division, and headquartered in Newark, New York, the Company’s business segments include battery and energy products and communications systems.3
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Business segments
Battery & Energy Products brought in 93% of the revenue Ultralife Corporation broke down this way in fiscal 2025.
Business segments by year
| Business segments | 2024 | 2025 |
|---|---|---|
| Battery & Energy Products | $144.1M | $178.0M |
| Communications Systems | $20.4M | $13.1M |
Regions
United States brought in 72% of the revenue Ultralife Corporation broke down this way in fiscal 2025.
Regions by year
| Regions | 2024 | 2025 |
|---|---|---|
| United States | $97.0M | $137.1M |
| Outside the United States | $67.4M | $54.1M |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue76¢$145.1M
- Research and development5¢$10.4M
- Selling, general and admin15¢$29.3M
- Other costs2¢$3.8M
- Income tax1¢$2.4M
Out of $191.2M in revenue.8 The company lost money this year.
Where each dollar of operating cash went, fiscal 2025
- Capital spending35¢$3.9M
- Kept or used elsewhere65¢$7.1M
Out of $11.0M of cash from operations.8
Financial statements
Every line of the income statement as filed: the last 2 fiscal years, latest first.8
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Revenues | $191.2M | $164.5M |
| Cost of products sold | $145.1M | $122.1M |
| Gross profit | $46.0M | $42.3M |
| Research and development | $10.4M | $8.3M |
| Selling, general and administrative | $29.3M | $24.1M |
| Intangible asset impairment | -$12.2M | $0 |
| Total operating expenses | $51.9M | $32.3M |
| Operating (loss) income | -$5.9M | $10.0M |
| Interest and financing expense | $4.0M | $1.9M |
| Miscellaneous income | -$1.5M | -$276.0K |
| Total other expense, net | $2.5M | $1.7M |
| (Loss) income before income taxes | -$8.4M | $8.3M |
| Income tax (benefit) provision | -$2.4M | $1.9M |
| Net (loss) income | -$6.0M | $6.4M |
| Net (loss) income attributable to non-controlling interest | -$53.0K | $97.0K |
| (Loss) income attributable to Ultralife Corporation | -$5.9M | $6.3M |
| Foreign currency translation adjustments | $865.0K | -$346.0K |
| Comprehensive (loss) income attributable to Ultralife Corporation | -$5.0M | $6.0M |
| Net (loss) income per share attributable to Ultralife Corporation common stockholders Basic (in dollars per share) | -$35.00 | $38.00 |
| Net (loss) income per share attributable to Ultralife Corporation common stockholders Diluted (in dollars per share) | -$35.00 | $38.00 |
| Weighted average shares outstanding Basic (in shares) | 16.6M shares | 16.6M shares |
| Weighted average shares outstanding Diluted (in shares) | 16.6M shares | 16.8M shares |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 3 fiscal years (annual) or 3 quarters (quarterly), latest first.8
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash | $9.3M | $6.9M | |
| Trade accounts receivable, net of allowance for expected credit losses of $457 and $384, respectively | $33.9M | $29.4M | |
| Inventories, net | $54.0M | $51.4M | |
| Prepaid expenses and other current assets | $8.5M | $9.6M | |
| Total current assets | $105.8M | $97.2M | |
| Property, plant and equipment, net | $40.4M | $40.5M | |
| Goodwill | $45.4M | $45.0M | |
| Other intangible assets, net | $10.9M | $24.6M | |
| Deferred income taxes, net | $10.5M | $8.4M | |
| Other noncurrent assets | $3.9M | $4.8M | |
| Total assets | $216.9M | $220.5M | |
| Accounts payable | $17.4M | $14.2M | |
| Current portion of long-term debt | $4.1M | $2.8M | |
| Accrued compensation and related benefits | $2.8M | $2.9M | |
| Accrued expenses and other current liabilities | $13.0M | $9.5M | |
| Total current liabilities | $37.3M | $29.3M | |
| Long-term debt, net | $45.5M | $51.5M | |
| Deferred income taxes | $1.0M | $1.4M | |
| Other noncurrent liabilities | $2.9M | $4.0M | |
| Total liabilities | $86.8M | $86.3M | |
| Preferred stock par value $.10 per share; authorized 1,000,000 shares; none issued | $0 | $0 | |
| Common stock par value $.10 per share; authorized 40,000,000 shares; issued 21,092,617 shares and 21,069,079 shares, respectively; outstanding 16,656,503 shares and 16,632,965 shares, respectively | $2.1M | $2.1M | |
| Capital in excess of par value | $192.9M | $191.8M | |
| Accumulated deficit | -$40.3M | -$34.4M | |
| Accumulated other comprehensive loss | -$3.1M | -$4.0M | |
| Treasury stock - at cost; 4,436,114 shares and 4,436,114 shares, respectively | -$21.5M | -$21.5M | |
| Total Ultralife Corporation equity | $130.0M | $134.0M | |
| Non-controlling interest | $139.0K | $192.0K | |
| Total stockholders equity | $130.1M | $134.2M | $125.4M |
| Total liabilities and stockholders equity | $216.9M | $220.5M | |
| Trade accounts receivable, allowance for doubtful accounts | $457.0K | $384.0K | |
| Preferred stock, par value (in dollars per share) | $0.10 | $0.10 | |
| Preferred Stock, Shares Authorized (in shares) | 1.0M shares | 1.0M shares | |
| Preferred Stock, Shares Issued (in shares) | 0 shares | 0 shares | |
| Common stock, par value (in dollars per share) | $0.10 | $0.10 | |
| Common Stock, Shares Authorized (in shares) | 40.0M shares | 40.0M shares | |
| Common stock, shares issued (in shares) | 21.1M shares | 21.1M shares | |
| Common stock, shares outstanding (in shares) | 16.7M shares | 16.6M shares | |
| Treasury Stock, Common, Shares (in shares) | 4.4M shares | 4.4M shares |
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash | $9.3M | $6.9M | |
| Trade accounts receivable, net of allowance for expected credit losses of $457 and $384, respectively | $33.9M | $29.4M | |
| Inventories, net | $54.0M | $51.4M | |
| Prepaid expenses and other current assets | $8.5M | $9.6M | |
| Total current assets | $105.8M | $97.2M | |
| Property, plant and equipment, net | $40.4M | $40.5M | |
| Goodwill | $45.4M | $45.0M | |
| Other intangible assets, net | $10.9M | $24.6M | |
| Deferred income taxes, net | $10.5M | $8.4M | |
| Other noncurrent assets | $3.9M | $4.8M | |
| Total assets | $216.9M | $220.5M | |
| Accounts payable | $17.4M | $14.2M | |
| Current portion of long-term debt | $4.1M | $2.8M | |
| Accrued compensation and related benefits | $2.8M | $2.9M | |
| Accrued expenses and other current liabilities | $13.0M | $9.5M | |
| Total current liabilities | $37.3M | $29.3M | |
| Long-term debt, net | $45.5M | $51.5M | |
| Deferred income taxes | $1.0M | $1.4M | |
| Other noncurrent liabilities | $2.9M | $4.0M | |
| Total liabilities | $86.8M | $86.3M | |
| Preferred stock par value $.10 per share; authorized 1,000,000 shares; none issued | $0 | $0 | |
| Common stock par value $.10 per share; authorized 40,000,000 shares; issued 21,092,617 shares and 21,069,079 shares, respectively; outstanding 16,656,503 shares and 16,632,965 shares, respectively | $2.1M | $2.1M | |
| Capital in excess of par value | $192.9M | $191.8M | |
| Accumulated deficit | -$40.3M | -$34.4M | |
| Accumulated other comprehensive loss | -$3.1M | -$4.0M | |
| Treasury stock - at cost; 4,436,114 shares and 4,436,114 shares, respectively | -$21.5M | -$21.5M | |
| Total Ultralife Corporation equity | $130.0M | $134.0M | |
| Non-controlling interest | $139.0K | $192.0K | |
| Total stockholders equity | $130.1M | $134.2M | $125.4M |
| Total liabilities and stockholders equity | $216.9M | $220.5M | |
| Trade accounts receivable, allowance for doubtful accounts | $457.0K | $384.0K | |
| Preferred stock, par value (in dollars per share) | $0.10 | $0.10 | |
| Preferred Stock, Shares Authorized (in shares) | 1.0M shares | 1.0M shares | |
| Preferred Stock, Shares Issued (in shares) | 0 shares | 0 shares | |
| Common stock, par value (in dollars per share) | $0.10 | $0.10 | |
| Common Stock, Shares Authorized (in shares) | 40.0M shares | 40.0M shares | |
| Common stock, shares issued (in shares) | 21.1M shares | 21.1M shares | |
| Common stock, shares outstanding (in shares) | 16.7M shares | 16.6M shares | |
| Treasury Stock, Common, Shares (in shares) | 4.4M shares | 4.4M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 2 fiscal years, latest first.8
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net income | -$6.0M | $6.4M |
| Depreciation | $4.0M | $3.1M |
| Amortization of intangible assets | $1.5M | $1.0M |
| Intangible asset impairment | $12.2M | $0 |
| Amortization of financing fees | $265.0K | $91.0K |
| Debt modification expense | $0 | $162.0K |
| Stock-based compensation | $935.0K | $698.0K |
| Deferred income tax expense | -$2.5M | $1.2M |
| Accounts receivable | -$4.4M | $7.6M |
| Inventories | -$2.3M | -$109.0K |
| Prepaid expenses and other assets | $1.7M | -$3.8M |
| Income taxes receivable and payable | -$170.0K | -$64.0K |
| Accounts payable and other liabilities | $5.8M | $215.0K |
| Net cash provided by operating activities | $11.0M | $16.6M |
| Purchase of Electrochem | $0 | -$48.0M |
| Purchases of property, plant and equipment | -$3.9M | -$1.9M |
| Net cash used in investing activities | -$3.9M | -$50.0M |
| Borrowings on credit facility | $0 | $55.0M |
| Payment of debt issuance costs | $24.0K | $1.4M |
| Proceeds from exercise of stock options | $98.0K | $2.0M |
| Net cash used in financing activities | -$4.7M | $29.9M |
| Effect of exchange rate changes on cash | $49.0K | $34.0K |
| INCREASE (DECREASE) IN CASH | $2.5M | -$3.4M |
| Construction in process in accounts payable | $424.0K | $248.0K |
| Income taxes paid | $147.0K | $722.0K |
| Interest paid | $3.7M | $1.9M |
No quarter-by-quarter statement was filed.
Corporate structure
Ultralife Corporation sits at the top of its group. 8 entities, 4 countries on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of Ultralife Corporation
- Bradford T. Whitmore Filed SCHEDULE 13D/A on Ultralife Corporation, latest Mar 16, 2026 (2 filings since Sep 3, 2024)
- Visionary Wealth Advisors Filed SCHEDULE 13G on Ultralife Corporation, latest Feb 13, 2026 (5 filings since Feb 15, 2022)
- DIMENSIONAL FUND ADVISORS LP Filed SC 13G/A on Ultralife Corporation, latest Feb 9, 2024 (3 filings since Feb 8, 2022)
- Ultralife Corporation Newark, New York, United States
- Through our ownership interest in Ultralife UK LTD, we have a 100% controlling interest in Accutronics, Ltd., also incorporated in Subsidiary · United Kingdom
- We have 100% ownership interest in Electrochem Solutions, Inc., incorporated in Subsidiary · Massachusetts, United States
- We have 100% ownership interest in Southwest Electronic Energy Corporation and its wholly owned subsidiary, CLB, Inc. (collectively “SWE”), both incorporated in Subsidiary · Texas, United States
- We have a 100% ownership interest in ABLE New Energy Co., Limited, incorporated in Hong Kong, which has a 100% ownership interest in ABLE New Energy Co., Ltd, incorporated in the People’s Republic of Subsidiary · China
- We have a 100% ownership interest in Ultralife Batteries (UK) LTD, incorporated in Subsidiary · United Kingdom
- We have a 100% ownership interest in Ultralife Energy Services Corporation, incorporated in Subsidiary · Florida, United States
- We have a 51% ownership interest in Ultralife Batteries India Private Limited, incorporated in Subsidiary · India
Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.
What it owns
What Ultralife Corporation reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Property and equipment, before depreciation | $112.9M8 Dec 31, 2025 | $108.9M8 Dec 31, 2024 | +3.7% |
| Accumulated depreciation | $72.5M8 Dec 31, 2025 | $68.4M8 Dec 31, 2024 | +6.0% |
| Property and equipment, net | $40.4M8 Dec 31, 2025 | $40.5M8 Dec 31, 2024 | −0.2% |
| Operating-lease assets (leased space) | $3.3M8 Dec 31, 2025 | $4.2M8 Dec 31, 2024 | −19.5% |
Investments
Intangibles and goodwill
| Item | Latest | A year before | Change |
|---|---|---|---|
| Goodwill | $45.4M8 Dec 31, 2025 | $45.0M8 Dec 31, 2024 | +0.8% |
| Finite-lived intangibles, gross | $25.6M8 Dec 31, 2025 | $38.7M8 Dec 31, 2024 | −33.8% |
| Accumulated amortization | $14.7M8 Dec 31, 2025 | $14.1M8 Dec 31, 2024 | +3.8% |
| Finite-lived intangibles, net | $10.9M8 Dec 31, 2025 | $24.6M8 Dec 31, 2024 | −55.5% |
Inventory
| Item | Latest | A year before | Change |
|---|---|---|---|
| Inventory, total | $54.0M8 Dec 31, 2025 | $51.4M8 Dec 31, 2024 | +5.1% |
| Raw materials | $42.1M8 Dec 31, 2025 | $36.0M8 Dec 31, 2024 | +17.0% |
| Work in process | $4.0M8 Dec 31, 2025 | $4.5M8 Dec 31, 2024 | −10.1% |
| Finished goods | $7.8M8 Dec 31, 2025 | $10.8M8 Dec 31, 2024 | −27.8% |
Properties, in its own words
As of December 31, 2025, we own two buildings in Newark, New York comprising approximately 250,000 square feet, which serve operations primarily in the Battery & Energy Products operating segment. Our corporate headquarters are located in our Newark, New York facility. We own one building in Missouri City, Texas comprising 69,000 square feet, which houses our Ultralife Houston operations and one building in Raynham, Massachusetts comprising 82,000 square feet, which houses our Ultralife Raynham operations, and lease approximately 97,000 square feet in two buildings on one campus in Shenzhen, China, including a dormitory facility, approximately 25,000 square feet in six buildings in a contiguous area in Newcastle-under-Lyme, United Kingdom, and approximately 10,000 square feet in a facility for our Ultralife Canada operations located in Calgary, all which serve operations in the Battery & Energy Products operating segment. We lease approximately 32,500 square feet in a facility in Virginia Beach, Virginia, which serves operations in the Communications Systems operating segment. We also lease sales and administrative offices, as well as manufacturing and production facilities, in India, which serve operations in the Battery & Energy Products operating segment. Our research and development efforts for Battery & Energy Products are conducted at our Newark, New York; Missouri City, Texas; Raynham, Massachusetts; Newcastle-under-Lyme, United Kingdom; Shenzhen, China; and our Canada facilities, while our research and development efforts for our Communications Systems products are conducted in our leased facilities in Tallahassee, Florida and in Virginia Beach, Virginia. We believe that our facilities are adequate and suitable for our current needs and provide sufficient capacity to produce our products to meet current demand.
Item 2 of the 10-K filed Mar 23, 2026.16
Leadership
Who has led Ultralife Corporation, and when. Pick a name to see everywhere that person has worked.
Chief financial officer
Chief operating officer
- Chief executive officerMichael Edward Manna Dec 15, 2022 to now17
- Chief executive officerMichael D. Popielec Jan 3, 2011 to Dec 21, 202118
- Chief executive officerJohn D. Kavazanjian Mar 27, 2006 to Mar 3, 201019
- PresidentMichael Edward Manna Dec 15, 2022 to now17
- PresidentMichael D. Popielec Jan 3, 2011 to Dec 21, 202118
- PresidentJohn D. Kavazanjian Mar 27, 2006 to Mar 3, 201019
- Chief financial officerPhilip A. Fain Jun 3, 2016 to Apr 19, 202420
- Chief financial officerJohn Charles Casper Jun 4, 2009 to Jun 11, 200921
- Chief financial officerRobert W. Fishback Jan 3, 2006 to Apr 22, 200922
- Chief operating officerWilliam A. Schmitz Jan 3, 2006 to Apr 16, 200923
Board members and other officers (21)
- Vice PresidentPhilip A. Fain Mar 10, 2008 to Mar 9, 201524
- VP of Corporate MarketingJulius M. Cirin Jan 3, 2006 to Mar 3, 201025
- VP of Sales & MarketingNancy C. Naigle Jan 3, 2006 to Apr 3, 200626
- VP Corporate Business StrategyPatrick R. Hanna Jr. Jan 3, 2006 to Dec 7, 201027
- Vice President of QualityAndrew J. Naukam Jun 12, 2006 to Mar 4, 200928
- Vice PresidentThomas E. Hauke Jul 11, 2006 to Sep 12, 200629
- Board memberJanie Goddard Mar 1, 2023 to now30
- Board memberMichael Edward Manna Dec 15, 2022 to now17
- Board memberMichael D. Popielec Jan 3, 2011 to Dec 21, 202118
- Board memberJames A. Croce Jun 9, 2010 to Nov 15, 201231
- Board memberW. Shaw Robert Jun 9, 2010 to now32
- Board memberBradford T. Whitmore Jul 5, 2007 to now33
- Board memberAnthony J. Cavanna Jan 3, 2006 to May 17, 201034
- Board memberCarl H. Rosner Jan 3, 2006 to Apr 3, 200635
- Board memberDaniel W. Christman Jan 3, 2006 to Feb 22, 201036
- Board memberPatricia C. Barron Jan 3, 2006 to Nov 15, 201237
- Board memberPaula H. Cholmondeley Jan 3, 2006 to May 17, 201038
- Board memberRanjit C. Singh Jan 3, 2006 to Aug 18, 201439
- Board memberJohn D. Kavazanjian Mar 27, 2006 to Mar 3, 201019
- Board memberCarole Lewis Anderson Jun 12, 2006 to May 17, 201040
- General counselPeter F. Comeford Jan 3, 2006 to Dec 13, 201141
Products and brands
Battery and energy products
This segment manufactures and markets Lithium Manganese Dioxide (Li-MnO2), Lithium Manganese Dioxide Carbon Monofluoride (Li-CFx/MnO2) hybrid and Lithium Thionyl Chloride (Li-SOCl2) non-rechargeable batteries including 9-volt, HiRate cylindrical, ThinCell, and others. Applications for its 9-volt batteries include smoke alarms, wireless security systems, and intensive care monitors. Its HiRate and ThinCell Lithium non-rechargeable batteries are sold primarily to the military and to OEMs in industrial markets for use in radios, emergency radio beacons, search and rescue transponders, pipeline inspection gauges, portable medical devices and other instruments and applications. Military applications for its non-rechargeable HiRate batteries include manpack and survival radios, night vision devices, targeting devices, chemical agent monitors, and thermal imaging equipment.
Communications systems
Under McDowell Research and AMTI brands, this segment designs and manufactures a line of communications systems and accessories for the military. All systems are packaged to meet customer needs in rugged enclosures to allow for their use in extreme environments. The segment markets these products to all permitted branches of the U.S. military and foreign defense organizations, as well as U.S. and international defense contractors.
From Wikipedia’s article on Ultralife Corporation, shared under CC BY-SA 4.0.6
Subsidiaries and ownership
Subsidiaries (Exhibit 21)
- Through our ownership interest in Ultralife UK LTD, we have a 100% controlling interest in Accutronics, Ltd., also incorporated in the United Kingdom.7
- We have 100% ownership interest in Electrochem Solutions, Inc., incorporated in Massachusetts.7
- We have 100% ownership interest in Southwest Electronic Energy Corporation and its wholly owned subsidiary, CLB, Inc. (collectively “SWE”), both incorporated in Texas.7
- We have a 100% ownership interest in ABLE New Energy Co., Limited, incorporated in Hong Kong, which has a 100% ownership interest in ABLE New Energy Co., Ltd, incorporated in the People’s Republic of China.7
- We have a 100% ownership interest in Ultralife Batteries (UK) LTD, incorporated in the United Kingdom.7
- We have a 100% ownership interest in Ultralife Energy Services Corporation, incorporated in Florida.7
- We have a 51% ownership interest in Ultralife Batteries India Private Limited, incorporated in India.7
The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.
Employees over time
- 20195731
Former names
- ULTRALIFE BATTERIES INCOct 6, 1995 to Jun 4, 20085
Timeline
- Aug 7, 20268-K Results of operations42
- Jul 23, 20268-K Shareholder vote43
- May 8, 20268-K Results of operations44
- Mar 10, 20268-K Results of operations45
- Nov 18, 20258-K Results of operations46
- Aug 27, 20258-K Change of auditor47
- Aug 7, 20258-K Results of operations48
- Jul 17, 20258-K Shareholder vote49
- May 9, 20258-K Results of operations50
- Apr 1, 20258-K Results of operations51
- Jan 16, 20258-K Financial statements and exhibits52
- Nov 8, 20248-K Results of operations53
- Dec 15, 2022New chief executive Michael Edward Manna becomes CEO17
- Jan 3, 2011New chief executive Michael D. Popielec becomes CEO18
- Mar 27, 2006New chief executive John D. Kavazanjian becomes CEO19
- 1990Founded Founded1
Calendar
Coming up
- Nov 17, 2026Reports results for the quarter ending Sep/202654
When it reported results
- Aug 7, 2026Reported quarterly or annual results42
- May 8, 2026Reported quarterly or annual results44
- Mar 10, 2026Reported quarterly or annual results45
- Nov 18, 2025Reported quarterly or annual results46
- Aug 7, 2025Reported quarterly or annual results48
- May 9, 2025Reported quarterly or annual results50
- Apr 1, 2025Reported quarterly or annual results51
- Nov 8, 2024Reported quarterly or annual results53
Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar
Filings
160 filings to the SEC since October 2021: 10 annual reports, 15 quarterly reports, 37 major events, 65 insider forms, 10 large holders, 23 other. The latest 20:
- Aug 7, 20268-K EDGAR
- Aug 7, 202610-Q EDGAR
- Jul 23, 20268-K EDGAR
- Jun 2, 2026DEFA14A EDGAR
- Jun 2, 2026DEF 14A EDGAR
- Jun 1, 2026SD EDGAR
- May 26, 20264 PRIMARY DOCUMENT EDGAR
- May 18, 20264 EDGAR
- May 8, 202610-Q EDGAR
- May 8, 20268-K EDGAR
- Apr 29, 202610-K/A EDGAR
- Mar 23, 202610-K EDGAR
- Mar 17, 2026NT 10-K EDGAR
- Mar 16, 20264 EDGAR
- Mar 16, 2026SCHEDULE 13D/A EDGAR
- Mar 16, 20264 PRIMARY DOCUMENT EDGAR
- Mar 10, 20268-K EDGAR
- Feb 13, 2026SCHEDULE 13G EDGAR
- Jan 5, 20264 PRIMARY DOCUMENT EDGAR
- Dec 16, 20254 PRIMARY DOCUMENT EDGAR
The 160 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
87 open-market trades by officers, directors and large owners since October 2021: 87 buys and 0 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| May 26, 2026 | WHITMORE BRADFORD TDirector | Buy | 67,302 | $6.81 | $458.3K | Form 4 |
| May 22, 2026 | WHITMORE BRADFORD TDirector | Buy | 8,700 | $6.33 | $55.1K | Form 4 |
| May 21, 2026 | WHITMORE BRADFORD TDirector | Buy | 32,876 | $6.13 | $201.5K | Form 4 |
| May 18, 2026 | Manna Michael EdwardPresident and CEO | Buy | 2,000 | $6.47 | $12.9K | Form 4 |
| Mar 16, 2026 | WHITMORE BRADFORD TDirector | Buy | 53,131 | $6.76 | $359.2K | Form 4 |
| Mar 13, 2026 | WHITMORE BRADFORD TDirector | Buy | 100,640 | $6.32 | $636.0K | Form 4 |
| Mar 12, 2026 | Manna Michael EdwardPresident and CEO | Buy | 2,000 | $6.01 | $12.0K | Form 4 |
| Mar 12, 2026 | WHITMORE BRADFORD TDirector | Buy | 33,741 | $5.97 | $201.4K | Form 4 |
| Dec 16, 2025 | WHITMORE BRADFORD TDirector | Buy | 28,588 | $5.70 | $163.0K | Form 4 |
| Dec 15, 2025 | Goddard JanieDirector | Buy | 1,739 | $5.75 | $10.0K | Form 4 |
| Dec 15, 2025 | WHITMORE BRADFORD TDirector | Buy | 14,882 | $5.66 | $84.2K | Form 4 |
| Dec 12, 2025 | WHITMORE BRADFORD TDirector | Buy | 9,530 | $5.63 | $53.7K | Form 4 |
| Nov 24, 2025 | Robert W. ShawDirector | Buy | 1,750 | $5.67 | $9.9K | Form 4 |
| Nov 19, 2025 | Manna Michael EdwardPresident and CEO | Buy | 2,000 | $4.96 | $9.9K | Form 4 |
| Nov 19, 2025 | WHITMORE BRADFORD TDirector | Buy | 53,900 | $4.97 | $267.9K | Form 4 |
| Aug 21, 2025 | WHITMORE BRADFORD TDirector | Buy | 29,766 | $6.63 | $197.3K | Form 4 |
| Aug 20, 2025 | WHITMORE BRADFORD TDirector | Buy | 13,000 | $6.57 | $85.4K | Form 4 |
| Aug 19, 2025 | WHITMORE BRADFORD TDirector | Buy | 15,898 | $6.56 | $104.3K | Form 4 |
| Jun 13, 2025 | Goddard JanieDirector | Buy | 1,548 | $7.68 | $11.9K | Form 4 |
| Jun 13, 2025 | WHITMORE BRADFORD TDirector | Buy | 10,000 | $7.64 | $76.4K | Form 4 |
All 87 trades can be filtered by person here when JavaScript is on.
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- Bradford T. WhitmoreSCHEDULE 13D/A, 2 filings Sep 3, 2024 to Mar 16, 202655
- Visionary Wealth AdvisorsSCHEDULE 13G, 5 filings Feb 15, 2022 to Feb 13, 202656
- DIMENSIONAL FUND ADVISORS LPSC 13G/A, 3 filings Feb 8, 2022 to Feb 9, 202457
Executive pay
What the company paid its top executives, from the summary compensation table in its proxy statement. Total pay includes salary, bonus, stock and option awards and other pay, as the company valued them.
| Year | Executive | Age | Salary | Total pay |
|---|---|---|---|---|
| 2025 | Michael E. MannaPresident and Chief | 56 | $415.0K | $434.1K58 |
| 2025 | Philip A. FainChief Financial Officer, Treasurer | 71 | $370.1K | $394.1K58 |
| 2024 | Executive Officer (Current) | $388.5K | $489.2K58 | |
| 2024 | and Secretary | $360.2K | $446.0K58 |
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 51. Change is in shares since the quarter before.
| Fund | Shares | Value | Share of the fund | Change |
|---|---|---|---|---|
| Visionary Wealth Advisors | 1,109,170 | $7.0M | 0.3% | +3,016 |
| Dimensional Fund Advisors LP | 963,733 | $6.1M | 0.0% | −31,113 |
| Vanguard Capital Management LLC | 464,730 | $2.9M | 0.0% | +6,893 |
| Truffle Hound Capital, LLC | 250,000 | $1.6M | 1.0% | No change |
| RBF Capital, LLC | 218,714 | $1.4M | 0.1% | No change |
| Renaissance Technologies LLC | 171,790 | $1.1M | 0.0% | −26,300 |
| Connor, Clark & Lunn Investment Management Ltd. | 155,043 | $979.9K | 0.0% | +22 |
| BlackRock, Inc. | 154,406 | $975.8K | 0.0% | +8,133 |
| Raymond James Financial Inc | 136,696 | $863.9K | 0.0% | −2,637 |
| Arrowstreet Capital, Limited Partnership | 126,753 | $801.1K | 0.0% | No change |
| Geode Capital Management, LLC | 125,776 | $795.5K | 0.0% | −1,563 |
| Teton Advisors, LLC | 109,000 | $688.9K | 0.4% | No change |
| Russell Investments Group, Ltd. | 72,490 | $458.1K | 0.0% | −9,301 |
| Vanguard Fiduciary Trust Co | 63,496 | $401.3K | 0.0% | +430 |
| Bridgeway Capital Management, LLC | 59,579 | $376.5K | 0.0% | No change |
| Ancora Advisors LLC | 56,169 | $355.0K | 0.0% | No change |
| Two Sigma Investments, LP | 51,106 | $323.0K | 0.0% | −11,119 |
| Maridea Wealth Management LLC | 42,708 | $269.9K | 0.0% | New |
| State Street Corp | 42,470 | $268.4K | 0.0% | −350 |
| Ameriprise Financial Inc | 36,521 | $230.8K | 0.0% | +371 |
| Man Group plc | 33,727 | $213.2K | 0.0% | +10,637 |
| Citadel Advisors LLC | 25,283 | $159.8K | 0.0% | −16,018 |
| Marshall Wace, Llp | 24,435 | $154.4K | 0.0% | +13,357 |
| Northern Trust Corp | 24,095 | $152.3K | 0.0% | −5,136 |
| Walleye Capital LLC | 23,296 | $147.2K | 0.0% | −9,584 |
13F reports cover disclosed long positions in U.S. stocks only.
SEC filer profile
How Ultralife Corporation is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARULTRALIFE CORP2
- CIK0000875657
- Employer ID (EIN)16-138701316
- Filer statusAccelerated filer not an emerging growth company; a smaller reporting company; not a shell company16
- Incorporated inDelaware16
- Fiscal year endsDecember 312
- Industry code (SIC)3690 Miscellaneous Electrical Machinery, Equipment & Supplies2
- SEC reviewing officeOffice of Manufacturing, Division of Corporation Finance2
- Business address2000 Technology Parkway, Newark, NY 145132
- Phone31533271002
- Shares outstanding16,663,269 as of Aug 3, 202615
- Public float$90.5M as of Jun 30, 202516
- AuditorWithumSmith+Brown, PC, Rochester, New York PCAOB ID 100; it also attests to the company’s internal control over financial reporting16
- On EDGAR sinceOct 6, 19952
- Filings1,711 in all: 4 (866), 8-K (350), 10-Q (91), SC 13G/A (70), 4/A (51), SC 13G (32), 10-K (31), DEF 14A (31)2
All 36 form types
3 (21), SC 13D/A (18), 10-K/A (14), 8-K/A (14), ARS (13), DEFA14A (13), SD (13), S-8 (11), UPLOAD (11), NT 10-K (8), 10-Q/A (7), CORRESP (7), S-3 (7), S-3/A (6), 424B3 (5), EFFECT (3), NT 10-Q (3), PRE 14A (3), SC 13D (2), SCHEDULE 13G (2), 424B5 (1), 5 (1), 6-K (1), DEFS14A (1), FWP (1), PRES14A (1), REGDEX (1), SCHEDULE 13D/A (1)
- Latest filingsAnnual report (10-K) Mar 23, 2026
Quarterly report (10-Q) Aug 7, 2026
Proxy statement (DEF 14A) Jun 2, 2026
Latest 8-K (8-K) Aug 7, 2026
Securities registered for trading
| Class | Symbol | Exchange |
|---|---|---|
| Common Stock, $0.10 par value per share | ULBI | NASDAQ |
From the cover page of the 10-K filed Mar 23, 2026 (Section 12(b) of the Exchange Act).16
Risk factors and legal proceedings
The risks Ultralife Corporation names in Item 1A of its 10-K filed Mar 23, 2026: 30 risks under these headings, as written.16
- Company Risk Factors
- Changes in economic conditions, including inflation, government trade policies, tariffs, interest rates, and supply-chain disruptions have affected and may continue to affect our business, revenues and earnings adversely.
- A significant portion of our revenue is derived from certain key customers.
- Reductions or delays in U.S. and foreign military spending could have a material adverse effect on our business, financial condition and results of operations.
- Our efforts to develop new products or new commercial applications for our products and the subsequent transition to high-volume production could be prolonged, not be profitable, not be accepted by our customers or could otherwise fail to achieve market share.
- Our supply of raw materials and components could be disrupted or delayed due to business conditions, new or additional tariffs, global conflicts, weather, sourcing requirements or other factors not under our control, or the cost of those raw materials and components may materially increase.
- Our growth and expansion strategy could strain or overwhelm our resources.
- Our ability to recruit and retain experienced, competent management is critical to the success of the business, and the loss of top management and key personnel could significantly harm our business, and the ability to implement our succession plan.
- Breaches in security, whether cyber or physical, and related disruptions and/or our inability to prevent or respond to such breaches, have previously, and in the future could diminish our ability to generate revenues or contain costs, compromise our assets, and negatively impact our business in other ways.
- Fluctuations in the demand, supply and price of oil and gas and the resulting volatility in the level of downhole drilling could have a material adverse effect on our business, financial condition and results of operations.
- Our operations in China are subject to unique risks and uncertainties, including political changes, tariffs and trade restrictions.
- A decline in demand for products using our batteries or communications systems could reduce demand for our products and/or our products could become obsolete resulting in lower revenues and profitability.
The other 19 risks
- We are subject to certain safety risks, including the risk of fire or explosion, inherent in the manufacture, use and transportation of Lithium batteries. These risks also create the potential for claims against the Company, which can have a negative impact on our financial results.
- Our quarterly and annual results and the price of our common stock have and could in the future continue to fluctuate significantly.
- Our customers’ purchases may not meet the volume expectations in our supply agreements.
- Rising interest rates will increase the cost of our borrowing and will affect our earnings adversely.
- Any inability to comply with changes to the regulations for the shipment of our products could limit our ability to transport our products to customers in a cost-effective manner and reduce our operating income and margins.
- Our entrance into new markets could lead to additional exposure to financial risk or increased liability, and our failure to successfully enter into those markets could lead to negative customer perception or loss of business from existing customers.
- As a result of litigation or claims, currently known or unknown, we could experience negative optics in the market, disruptive demand on our management and staff’s time, and increased costs.
- The potential of future pandemics could create significant economic and social disruption and uncertainty around the world, may impact the health of our employees, the employees of our customers, and the employees of our suppliers, causing delays in the manufacture and delivery of our mission critical products to end customers, and may disrupt business with our collaborative business partners and service providers, which may continue to adversely impact our business and operating results.
- We may incur significant costs or liabilities to satisfy obligations under the terms of the warranties we supply and the contractual terms under which we sell our products and services.
- Negative publicity concerning Lithium-ion batteries may adversely impact the industries or markets in which we operate.
- We are subject to the contract rules and procedures of the U.S. and foreign governments. These rules and procedures create significant risks and uncertainties for us that are not usually present in contracts with private parties.
- We are subject to foreign currency fluctuations.
- Our ability to use our net operating loss and tax credit carryforwards in the future may be limited, which could increase our tax liabilities and reduce our cash flow and net income.
- A finding that our proprietary and intellectual property rights are not enforceable or invalid could allow our competitors and others to produce competing products based on our proprietary and intellectual property or limit our ability to manufacture and market our products, without significant, costly alterations.
- Compliance with government regulations regarding the use of "conflict minerals" may result in increased costs and risks to the Company.
- Any impairment of goodwill and/or other indefinite-lived intangible assets could adversely impact our results of operations.
- We may incur significant costs because of known and unknown environmental factors.
- The U.S. and foreign governments can audit our contracts with their respective defense and government agencies and, under certain circumstances, can adjust the economic terms, delivery schedule or other terms of those contracts.
- Our business and results of operations could be adversely affected by violations of the U.S. Foreign Corrupt Practices Act (“FCPA”), the U.K. Bribery Act or other anti-corruption laws.
Legal proceedings
We are subject to legal proceedings and claims that arise from time to time in the normal course of business. We believe that the final disposition of any such matters will not have a material adverse effect on the Company’s financial position, results of operations or cash flows. However, recognizing that legal matters are subject to inherent uncertainties, there exists the possibility that ultimate resolution of these matters could have a material adverse impact on the Company’s financial position, results of operations or cash flows. We are not aware of any such situations at this time.
The opening of Item 3, Legal Proceedings.16
Links
- Websiteultralifecorporation.com1
- WikipediaUltralife Corporation
- WikidataQ17086475
- SEC EDGARCIK 875657
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3WikipediaUltralife Corporation on Wikipedia
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24SEC EDGARPhilip A. Fain, Vice President
- 25
- 26
- 27
- 28
- 29SEC EDGARThomas E. Hauke, Vice President
- 30SEC EDGARJanie Goddard, Board member
- 31SEC EDGARJames A. Croce, Board member
- 32SEC EDGARW. Shaw Robert, Board member
- 33SEC EDGARBradford T. Whitmore, Board member
- 34SEC EDGARAnthony J. Cavanna, Board member
- 35SEC EDGARCarl H. Rosner, Board member
- 36SEC EDGARDaniel W. Christman, Board member
- 37SEC EDGARPatricia C. Barron, Board member
- 38SEC EDGARPaula H. Cholmondeley, Board member
- 39SEC EDGARRanjit C. Singh, Board member
- 40SEC EDGARCarole Lewis Anderson, Board member
- 41SEC EDGARPeter F. Comeford, General counsel
- 42SEC EDGARResults of operations
- 43SEC EDGARShareholder vote
- 44SEC EDGARResults of operations
- 45SEC EDGARResults of operations
- 46SEC EDGARResults of operations
- 47SEC EDGARChange of auditor
- 48SEC EDGARResults of operations
- 49SEC EDGARShareholder vote
- 50SEC EDGARResults of operations
- 51SEC EDGARResults of operations
- 52SEC EDGARFinancial statements and exhibits
- 53SEC EDGARResults of operations
- 54NasdaqNasdaq calendar
- 55
- 56
- 57
- 58